AVTR 주식 스냅샷 가격, 시가총액, P/E, EPS, ROE, 부채/자본, 52주 범위

03

가격 $15.34

시가총액 $10.46B

P/E (TTM) -18.3

EPS (TTM) $-0.84

매출 (TTM) $6.56B

ROE (TTM) -9.7%

부채/자본 (MRQ) 0.7

52주 범위 $7–$16

AVTR 주가 차트 기술 지표가 포함된 일일 OHLCV — 팬, 확대/축소 및 보기 사용자 정의

04

범위

막대

막대 세분성은 선택한 기간에 따라 조정됩니다. 막대의 시가/고가/저가/종가를 보려면 차트에 마우스를 올리세요.

Avantor, Inc. Common Stock 정보 위키백과 회사 개요

05 · wikidata

Avantor, Inc. is an American biotechnology, chemicals, and pharmaceutical company headquartered in Radnor, Pennsylvania. Established in 1904 as J.T. Baker, the company changed its name to Avantor in 2010. Avantor went public in 2019 and is now listed on the New York Stock Exchange under the symbol “AVTR”.

History

The company's history traces back to 1904, when John Townsend Baker (1860–1935) founded the chemical company J.T. Baker specializing in producing chemically pure reagents. The company gained recognition for its "Baker Analyzed" labels, which provided detailed analyses of trace impurities in its products. In 1911, the company began publishing "The Chemist-Analyst," which promoted its products and philosophy. After Baker's death in 1935, the company was acquired by Vick Chemical Company in 1941. During World War II, J.T. Baker expanded its product line to include penicillin, pesticides, and chemicals for batteries and munitions. After the war, the company further diversified into high-purity solvents, chromatography columns, and hazardous waste spill kits. In 1985, J.T. Baker and its parent company Richardson-Vicks were sold to Procter & Gamble, and subsequently sold to Mallinckrodt in 1995.

In 2010, investment firm New Mountain Capital purchased Mallinckrodt Baker Inc., which then changed its name to Avantor. The company extended its international market with the 2011 acquisitions of the Indian laboratory reagents supplier RFCL and the Polish lab supply firm POCH.

In 2016, Avantor merged with Nusil Technology. In 2017, Avantor acquired chemical blending business Puritan Products Inc. and laboratory supplies company VWR. The combined company operates under the Avantor name, with VWR and vwr.com remaining as a selling channel.

In May 2019, Avantor went public with a $3.8 billion initial public offering, which gave the company a market capitalization of $7.62 billion. As of December 2023, the top shareholders of Avantor included Vanguard Group Inc., Dodge & Cox Inc., T. Rowe Price Investment Management Inc., and BlackRock Inc.

That same year the company expanded further into Asia with the opening of an innovation center in Shanghai, which focuses on monoclonal antibodies and cell and gene therapy. In 2020, Avantor doubled the size of its Bridgewater, New Jersey innovation center, expanding its research and development capabilities and cell and gene therapy reagent manufacturing.

In 2020, Avantor began providing services and raw materials to companies manufacturing vaccines and other therapies to fight the COVID-19 pandemic. Avantor added employees and extra shifts in order to increase capacity for producing synthetic lipids that are formed into nanoparticles, which carry mRNA into human cells.

In June 2021, Avantor acquired China-based RIM Bio, a manufacturer of single-use bioprocess bags and assemblies for biopharmaceutical manufacturing applications.

Through the acquisition, Avantor gained access to RIM's Changzhou, China facility, marking Avantor's first single-use production plant in the Africa, Middle East, Asia (AMEA) region. The deal is part of a larger expansion of the company's single-use manufacturing footprint with plans to increase its presence by 30%.

The company ranked 485th in 2023 and 506 in 2024 on the Fortune 500, based on its sales records.

Controversies

On August 26, 2020, Bloomberg News implicated Avantor and other companies in the U.S. opioid epidemic. According to Bloomberg, one of their compounds "acetic anhydride", was used illicitly by drug traffickers to convert crude opium into heroin. Bloomberg also found evidence that Avantor's compound was used in cartel drug labs, and that regulations implemented in 2018 didn't stop it from being widely available. In response, Avantor discontinued all sales of acetic anhydride in Mexico and destroyed its existing inventory. In 2021, Texas Senator John Cornyn, who serves on both the Judiciary Committee and the bipartisan Caucus on International Narcotics Control claims that Avantor should have known better, selling acetic anhydride within Mexico's unregulated market. What should have raised eyebrows as well is that it was sold in 18-liter containers, which is inconsistent with the ordinary use of acetic anhydride. Four other Republican senators also deplored Avantor's “apparent longstanding contribution to the opioid epidemic that killed 50,000 of our fellow citizens in 2019.”

더 보기 접기

출처: 위키백과 (영어), CC BY-SA 4.0 · 위키백과에서 보기 ↗

Wikidata ↗

섹터Healthcare 산업Life Sciences Tools & Services 직원13,500 국가US

10년 성과 매출, 순이익, 마진 및 EPS 추세

06

매출$6.55B

2017-12-31 → 2025-12-31

EPS$-0.78

2018-12-31 → 2025-12-31

잉여현금흐름$495M

2019-12-31 → 2025-12-31

순이익률-8.8%

2019-12-31 → 2025-12-31

가치 평가 및 비율 07–12

가치 평가 P/E, P/S, P/B, EV/EBITDA 비율 — 주식이 비싼가요, 싼가요?

지표	AVTR	5년 평균	동종업계 중앙값	결론
P/E (TTM)	-18.35년 평균 ≈24.9	≈24.9	·	·
P/S	1.65년 평균 ≈2.2	≈2.2	3.7	저평가
P/B	1.95년 평균 ≈3.2	≈3.2	3.6	저평가
EV / EBITDA	-57.05년 평균 ≈10.3	≈10.3	·	·
Price / FCF (주가 / FCF)	21.15년 평균 ≈21.7	≈21.7	·	·
Price / Cash Flow (주가 / 현금 흐름)	16.85년 평균 ≈18.2	≈18.2	25.2	저평가
EV / Revenue (EV / 매출)	2.15년 평균 ≈2.9	≈2.9	·	·
EV / FCF	28.45년 평균 ≈28.9	≈28.9	·	·

동종 기업 중앙값은 지표별로 표준화된 기준으로 계산되며, 이 주식에 표시된 TTM/MRQ 기준과 항상 일치하지 않을 수 있습니다.

수익성 총, 영업 및 순이익률; ROE, ROA, ROIC

지표	AVTR	5년 평균	동종업계 중앙값	결론
매출 총이익률 (TTM)	31.8%5년 평균 ≈33.7%	≈33.7%	54.2%	약함
영업이익률 (TTM)	-4.6%5년 평균 ≈10.1%	≈10.1%	9.2%	평균 이하
EBITDA Margin (EBITDA 마진)	-3.8%5년 평균 ≈10.1%	≈10.1%	8.3%	약함
세전 마진 (TTM)	-7.2%5년 평균 ≈6.7%	≈6.7%	5.9%	평균 이하
순이익률 (TTM)	-8.8%5년 평균 ≈4.8%	≈4.8%	2.4%	동일
ROA (TTM)	-4.7%5년 평균 ≈2.7%	≈2.7%	-0.14%	약함
ROE (TTM)	-9.7%5년 평균 ≈7.6%	≈7.6%	-0.40%	약함
ROIC	-3.1%5년 평균 ≈5.1%	≈5.1%	1.1%	약함

재무 건전성 부채, 유동성, 지급능력 — 대차대조표 건전성

지표	AVTR	5년 평균	동종업계 중앙값	결론
부채 / 자기자본 비율 (MRQ)	0.75년 평균 ≈1.1	≈1.1	0.7	동일
유동비율 (MRQ)	1.85년 평균 ≈1.6	≈1.6	3.0	낮은 유동성
Quick Ratio (당좌 비율)	1.05년 평균 ≈0.9	≈0.9	1.6	평균 이하
장기 부채 / 자기 자본 (MRQ)	0.75년 평균 ≈1.0	≈1.0	0.7	동일

성장 매출, EPS 및 순이익 성장률: YoY, 3년 CAGR, 5년 CAGR

지표	AVTR	5년 평균	동종업계 중앙값	결론
Revenue YoY (매출 YoY)	-3.4%5년 평균 ≈0.78%	≈0.78%	·	·
Revenue CAGR 3Y (매출 CAGR 3년)	-4.5%5년 평균 ≈-1.4%	≈-1.4%	·	·
Revenue CAGR 5Y (매출 CAGR 5년)	0.49%	·	·	·
EPS YoY	121.3%5년 평균 ≈232.8%	≈232.8%	·	·
Net Income YoY (순이익 YoY)	121.6%5년 평균 ≈119.8%	≈119.8%	·	·
EPS CAGR 3Y (EPS CAGR 3년)	7.0%	·	·	·
Net Income CAGR 3Y (순이익 CAGR 3년)	7.5%	·	·	·

주당 지표 EPS, 주당 순자산, 주당 현금 흐름, 주당 배당금

지표	AVTR	5년 평균	동종업계 중앙값	결론
EPS (Diluted) (EPS (희석))	$-0.785년 평균 ≈$0.52	≈$0.52	·	·
Revenue / Share (주당 매출)	$9.635년 평균 ≈$10.64	≈$10.64	·	·
Cash Flow / Share (주당 현금 흐름)	$0.925년 평균 ≈$1.25	≈$1.25	·	·
Cash / Share (주당 현금)	$0.545년 평균 ≈$0.47	≈$0.47	·	·

자본 효율성 자산 회전율, 재고 회전율, 매출채권 회전율

지표	AVTR	5년 평균	동종업계 중앙값	결론
Asset Turnover (자산 회전율)	0.55년 평균 ≈0.6	≈0.6	0.5	동일
Inventory Turnover (재고 회전율)	5.75년 평균 ≈5.7	≈5.7	2.5	최상위권
Receivables Turnover (매출 채권 회전율)	6.25년 평균 ≈6.2	≈6.2	5.7	최상위권
Revenue / Employee (연간 매출액 ÷ 직원 수(yfinance 보고 인원수). 파생 — 저장된 SEC-XBRL 개념이 아님.)	≈$485.3K	·	·	·

가치 · ≈ 5년 평균 · 산업 중앙값 · 중앙값 대비 평가

실적 기록 EPS 실제 vs 예상, 서프라이즈 %, 달성률, 다음 실적 발표일

14

평균 서프라이즈 0.49%

다음 실적 10월 27, 2026

기간	보고서	EPS Actual	EPS 예상	서프라이즈
2026년 6월 30일	7월 30, 2026	$0.21	$0.19	8.6%
2026년 3월 31일		$0.17	$0.16	6.2%
2025년 12월 31일		$0.22	$0.22	-0.36%
2025년 9월 30일		$0.22	$0.23	-4.0%
2025년 6월 30일		$0.24	$0.25	-5.1%
2025년 3월 31일		$0.23	$0.24	-2.4%

전체 기본 지표 연도별 모든 지표 — 손익계산서, 대차대조표, 현금흐름

15

손익계산서 16

지표	2025	2024	2023	2022	2021	2020	2019	2018	2017
Revenue	$6.55B	$6.78B	$6.97B	$7.51B	$7.39B	$6.39B	$6.04B	$5.86B	$1.25B
Cost of Revenue	$4.41B	$4.50B	$4.60B	$4.91B	$4.88B	$4.31B	$4.12B	$4.04B	$815M
Gross Profit	$2.14B	$2.28B	$2.36B	$2.60B	$2.50B	$2.08B	$1.92B	$1.82B	$433M
SG&A Expense	$1.60B	$1.64B	$1.51B	$1.47B	$1.53B	$1.37B	$1.37B	$1.41B	$450M
Operating Income	$-246M	$1.08B	$696M	$1.13B	$972M	$707M	$552M	$414M	$-210M
Interest Expense	·	·	$285M	$266M	$217M	$308M	$440M	$524M	$201M
Interest Income	$42M	$75M	$65M	$16M	$2M	·	·	·	·
Other Non-op	$-21M	$-1M	$6M	$-800.0K	$11M	$10M	$2M	$-4M	$8M
Pretax Income	$-441M	$854M	$410M	$851M	$753M	$62M	$41M	$-114M	$-460M
Income Tax	$89M	$142M	$89M	$165M	$180M	$-54M	$3M	$-27M	$-315M
Net Income	$-530M	$712M	$321M	$686M	$573M	$117M	$38M	$-87M	$-113M
EPS (Basic)	$-0.78	$1.05	$0.48	$1.02	$0.86	$0.09	$-0.84	$-2.69	·
EPS (Diluted)	$-0.78	$1.04	$0.47	$1.01	$0.85	$0.09	$-0.84	$-2.69	·
Shares (Basic)	680,600,000	679,600,000	675,600,000	650,900,000	590,500,000	576,300,000	401,200,000	132,700,000	·
Shares (Diluted)	680,600,000	681,900,000	678,400,000	679,400,000	599,600,000	583,400,000	401,200,000	132,700,000	·
EBITDA	$-246M	$1.08B	$696M	$1.13B	$972M	$707M	$552M	·	·

대차대조표 26

지표	2025	2024	2023	2022	2021	2020	2019	2018	2017
Cash & Equivalents	$365M	$262M	$263M	$373M	$302M	$287M	$187M	$185M	·
Receivables	$1.07B	$1.03B	$1.15B	$1.22B	$1.22B	$1.11B	$989M	$931M	·
Inventory	$818M	$732M	$828M	$914M	$872M	$740M	$711M	$671M	·
Other Current Assets	$193M	$119M	$144M	$153M	$81M	$91M	$135M	$113M	·
Current Assets	$2.45B	$2.15B	$2.38B	$2.66B	$2.48B	$2.23B	$2.02B	$1.90B	·
PP&E (Net)	$767M	$708M	$738M	$727M	$706M	$550M	$557M	$599M	·
PP&E (Gross)	$1.51B	$1.34B	$1.35B	$1.25B	$1.15B	$938M	$865M	$824M	·
Accum. Depreciation	$745M	$630M	$617M	$518M	$445M	$388M	$308M	$226M	·
Goodwill	$4.99B	$5.54B	$5.72B	$5.65B	$5.34B	$2.86B	$2.77B	$2.78B	$2.85B
Intangibles	$3.10B	$3.27B	$3.68B	$4.04B	$5.05B	$3.96B	$4.13B	$4.47B	·
Other Non-current Assets	$396M	$360M	$358M	$294M	$233M	$217M	$205M	$63M	·
Total Assets	$11.79B	$12.11B	$12.97B	$13.46B	$13.90B	$9.91B	$9.77B	$9.91B	·
Accounts Payable	$742M	$663M	$626M	$758M	$755M	$679M	$560M	$557M	·
Current Liabilities	$1.38B	$2.01B	$1.48B	$1.66B	$1.45B	$1.24B	$1.07B	$1.10B	·
Capital Leases	$152M	$143M	$88M	$87M	$79M	·	$107M	·	·
Deferred Tax	$557M	$557M	$613M	$731M	$913M	$724M	$785M	$908M	·
Other Non-current Liabilities	$378M	$358M	$350M	$295M	$358M	$398M	$428M	$318M	·
Total Liabilities	$6.23B	$6.16B	$7.72B	$8.61B	$9.70B	$7.23B	$7.31B	$9.10B	·
Long-term Debt	$3.95B	$4.06B	$5.54B	$6.29B	$7.02B	$4.89B	$5.12B	$6.92B	·
Total Debt	$3.95B	$4.06B	$5.54B	$6.29B	$7.02B	$4.89B	$5.12B	·	·
Retained Earnings	$1.67B	$2.20B	$1.49B	$1.17B	$484M	$-89M	$-204M	$-238M	·
Treasury Stock	$76M	$0	·	·	·	·	·	·	·
AOCI	$-17M	$-184M	$-69M	$-100M	$-43M	$22M	$-86M	$-66M	$26M
Stockholders' Equity	$5.57B	$5.96B	$5.25B	$4.86B	$4.20B	$2.67B	$2.46B	$-3.05B	$-2.62B
Liabilities + Equity	$11.79B	$12.11B	$12.97B	$13.46B	$13.90B	$9.91B	$9.77B	$9.91B	·
Shares Outstanding	682,000,000	680,800,000	676,600,000	674,300,000	609,700,000	580,100,000	572,800,000	132,800,000	·

현금 흐름 18

지표	2025	2024	2023	2022	2021	2020	2019	2018	2017
D&A	$410M	$406M	$402M	$406M	$379M	$395M	$399M	$405M	$99M
Stock-based Comp	$46M	$47M	$40M	$46M	$51M	$44M	$68M	$18M	$48M
Deferred Tax	$8M	$-47M	$-172M	$-69M	$-18M	$-88M	$-107M	$-104M	$-431M
Amort. of Intangibles	$301M	$300M	$308M	$318M	$291M	$308M	$312M	$321M	$65M
Restructuring	$30M	$83M	$26M	$4M	$5M	$12M	$24M	$81M	$30M
Operating Cash Flow	$624M	$841M	$870M	$844M	$954M	$930M	$354M	$200M	$-168M
CapEx	$129M	$149M	$146M	$133M	$111M	$62M	$52M	$38M	$25M
Investing Cash Flow	$-130M	$439M	$-144M	$-110M	$-4.12B	$-59M	$-42M	$-23M	$-6.68B
Debt Issued	$1.11B	$0	$0	$327M	$2.83B	$3.94B	$1M	$36M	$9.25B
Net Debt Issued	$-319M	$-1.34B	$-846M	$-620M	$2.30B	$-423M	$-1.88B	·	·
Stock Issued	·	·	$0	$0	$967M	$0	$4.24B	·	·
Stock Repurchased	$75M	$0	$0	·	·	·	·	·	·
Net Stock Activity	$-75M	·	$0	$0	$967M	·	·	·	·
Financing Cash Flow	$-409M	$-1.28B	$-844M	$-649M	$3.22B	$-783M	$-308M	$-170M	$6.96B
Net Change in Cash	$104M	$-23M	$-109M	$70M	$38M	$100M	$2M	$-800.0K	$122M
Taxes Paid	$145M	$248M	$224M	$257M	$145M	$43M	$112M	$66M	$32M
Free Cash Flow	$495M	$692M	$724M	$710M	$842M	$868M	$302M	·	·
Levered FCF	·	·	$501M	$496M	$677M	$292M	$-107M	·	·

수익성 8

지표	2025	2024	2023	2022	2021	2020	2019	2018	2017
Gross Margin	32.6%	33.6%	33.9%	34.6%	33.9%	32.5%	31.8%	·	·
Operating Margin	-3.8%	16.0%	10.0%	15.0%	13.2%	11.1%	9.1%	·	·
Net Margin	-8.1%	10.5%	4.6%	9.1%	7.8%	1.8%	0.63%	·	·
Pretax Margin	-6.7%	12.6%	5.9%	11.3%	10.2%	0.97%	0.67%	·	·
EBITDA Margin	-3.8%	16.0%	10.0%	15.0%	13.2%	11.1%	9.1%	·	·
ROA	-4.4%	5.7%	2.4%	5.0%	4.8%	1.2%	0.38%	·	·
ROE	-8.9%	12.4%	6.2%	14.5%	13.8%	4.5%	1.6%	·	·
ROIC	-3.1%	9.0%	5.1%	8.2%	6.6%	17.5%	6.8%	·	·

유동성 및 지급능력 5

지표	2025	2024	2023	2022	2021	2020	2019	2018	2017
Current Ratio	1.8	1.1	1.6	1.6	1.7	1.8	1.9	·	·
Quick Ratio	1.0	0.6	1.0	1.0	1.1	1.1	1.1	·	·
Debt / Equity	0.7	0.7	1.1	1.3	1.7	1.8	2.1	·	·
LT Debt / Equity	0.7	0.5	1.0	1.2	1.7	1.8	2.0	·	·
Interest Coverage	·	·	2.4	4.3	4.5	2.3	1.3	·	·

효율성 3

지표	2025	2024	2023	2022	2021	2020	2019	2018	2017
Asset Turnover	0.5	0.5	0.5	0.5	0.6	0.6	0.6	·	·
Inventory Turnover	5.7	5.8	5.3	5.5	6.1	5.9	6.0	·	·
Receivables Turnover	6.2	6.2	5.9	6.2	6.3	6.1	6.3	·	·

주당 5

지표	2025	2024	2023	2022	2021	2020	2019	2018	2017
Book Value / Share	$8.16	$8.75	$7.76	$7.20	$6.88	$4.61	$4.30	·	·
Revenue / Share	$9.63	$9.95	$10.27	$11.06	$12.32	$10.96	·	·	·
Cash Flow / Share	$0.92	$1.23	$1.28	$1.24	$1.59	$1.59	·	·	·
Cash / Share	$0.54	$0.38	$0.39	$0.55	$0.49	$0.49	$0.33	·	·
EPS (TTM)	$-0.78	$1.04	$0.47	$1.01	$0.85	$0.09	$-0.84	·	·

성장률 7

지표	2025	2024	2023	2022	2021	2020	2019	2018	2017
Revenue YoY	-3.4%	-2.6%	-7.3%	1.7%	15.5%	·	·	·	·
Revenue CAGR 3Y	-4.5%	-2.8%	2.9%	·	·	·	·	·	·
Revenue CAGR 5Y	0.49%	·	·	·	·	·	·	·	·
EPS YoY	·	121.3%	-53.5%	18.8%	844.4%	·	·	·	·
EPS CAGR 3Y	·	7.0%	73.5%	·	·	·	·	·	·
Net Income YoY	·	121.6%	-53.2%	19.9%	391.1%	·	·	·	·
Net Income CAGR 3Y	·	7.5%	40.2%	·	·	·	·	·	·

가치 평가 (TTM) 13

지표	2025	2024	2023	2022	2021	2020	2019	2018	2017
Revenue TTM	$6.55B	$6.78B	$6.97B	$7.51B	$7.39B	$6.39B	$6.04B	·	·
Net Income TTM	$-530M	$712M	$321M	$686M	$573M	$117M	$38M	·	·
Market Cap	$7.82B	$14.34B	$15.45B	$14.22B	$25.69B	$16.33B	$10.40B	·	·
Enterprise Value	$11.40B	$18.14B	$20.72B	$20.14B	$32.41B	$20.94B	$15.33B	·	·
P/E	-14.7	20.3	48.6	20.9	49.6	312.8	-21.6	·	·
P/S	1.2	2.1	2.2	1.9	3.5	2.6	1.7	·	·
P/B	1.4	2.4	2.9	2.9	6.1	6.1	4.2	·	·
P / Cash Flow	12.5	17.1	17.8	16.9	26.9	17.6	29.4	·	·
P / FCF	15.8	20.7	21.3	20.0	30.5	18.8	34.4	·	·
EV / EBITDA	-46.3	16.7	29.8	17.8	33.3	29.6	27.8	·	·
EV / FCF	23.0	26.2	28.6	28.4	38.5	24.1	50.7	·	·
EV / Revenue	1.7	2.7	3.0	2.7	4.4	3.3	2.5	·	·
Earnings Yield	-6.8%	4.9%	2.1%	4.8%	2.0%	0.32%	-4.6%	·	·

손익계산서 16

지표	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Revenue	$1.69B	$1.58B	$1.66B	$1.62B	$1.68B	$1.58B	$1.69B	$1.71B	$1.70B	$1.68B	$1.72B	$1.72B	$1.74B	$1.78B	$1.79B	$1.86B
Cost of Revenue	$1.16B	$1.08B	$1.14B	$1.10B	$1.13B	$1.05B	$1.12B	$1.15B	$1.12B	$1.11B	$1.15B	$1.14B	$1.15B	$1.16B	$1.18B	$1.21B
Gross Profit	$537M	$501M	$524M	$526M	$554M	$535M	$563M	$564M	$582M	$570M	$570M	$579M	$590M	$625M	$614M	$651M
SG&A Expense	$415M	$401M	$392M	$390M	$425M	$388M	$371M	$440M	$406M	$424M	$387M	$368M	$358M	$394M	$363M	$375M
Operating Income	$122M	$100M	$126M	$-649M	$129M	$147M	$638M	$125M	$176M	$146M	$183M	$210M	$72M	$231M	$252M	$276M
Interest Expense	$39M	$43M	·	$44M	$43M	$42M	·	$49M	$61M	$64M	·	$72M	$73M	$74M	·	$67M
Interest Income	$10M	$10M	$11M	$12M	$11M	$8M	$12M	$27M	$18M	$18M	$18M	$17M	$16M	$14M	·	·
Other Non-op	$-600.0K	$-500.0K	$-1M	$4M	$-4M	$-20M	$-5M	$700.0K	$2M	$1M	$2M	$700.0K	$2M	$600.0K	$-6M	$3M
Pretax Income	$81M	$56M	$81M	$-690M	$82M	$86M	$584M	$74M	$115M	$81M	$120M	$136M	$-1M	$156M	$175M	$208M
Income Tax	$43M	$12M	$28M	$22M	$17M	$21M	$84M	$17M	$22M	$20M	$21M	$28M	$6M	$34M	$33M	$41M
Net Income	$38M	$43M	$52M	$-712M	$65M	$64M	$500M	$58M	$93M	$60M	$98M	$108M	$-7M	$122M	$142M	$167M
EPS (Basic)	$0.06	$0.06	$0.08	$-1.04	$0.09	$0.09	$0.74	$0.08	$0.14	$0.09	$0.15	$0.16	$-0.01	$0.18	$0.20	$0.25
EPS (Diluted)	$0.06	$0.06	$0.08	$-1.04	$0.09	$0.09	$0.73	$0.08	$0.14	$0.09	$0.14	$0.16	$-0.01	$0.18	$0.20	$0.25
Shares (Basic)	676,200,000	675,700,000	·	681,700,000	681,500,000	681,100,000	·	680,300,000	679,400,000	678,100,000	·	676,000,000	675,300,000	674,700,000	·	674,100,000
Shares (Diluted)	677,200,000	676,800,000	·	681,700,000	681,800,000	682,400,000	·	683,000,000	682,600,000	681,400,000	·	678,500,000	675,300,000	678,100,000	·	679,300,000
EBITDA	$122M	$100M	·	$-649M	$129M	$147M	·	$125M	$176M	$146M	·	$210M	$72M	$231M	·	$276M

대차대조표 26

지표	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Cash & Equivalents	$307M	$279M	$365M	$252M	$449M	$316M	$262M	$285M	$273M	$235M	·	$237M	$236M	$295M	·	$266M
Receivables	$1.14B	$1.10B	$1.07B	$1.08B	$1.15B	$1.10B	$1.03B	$1.09B	$1.13B	$1.13B	·	$1.15B	$1.22B	$1.28B	·	$1.23B
Inventory	$829M	$810M	$818M	$796M	$780M	$750M	$732M	$780M	$796M	$811M	·	$850M	$890M	$904M	·	$905M
Other Current Assets	$188M	$210M	$193M	$132M	$136M	$120M	$119M	$136M	$132M	$146M	·	$147M	$156M	$152M	·	$158M
Current Assets	$2.46B	$2.40B	$2.45B	$2.26B	$2.51B	$2.28B	$2.15B	$2.50B	$2.33B	$2.32B	·	$2.38B	$2.50B	$2.63B	·	$2.56B
PP&E (Net)	$772M	$766M	$767M	$762M	$759M	$736M	$708M	$723M	$754M	$740M	·	$698M	$698M	$736M	·	$698M
PP&E (Gross)	·	·	$1.51B	·	·	·	$1.34B	·	·	·	·	·	·	·	·	·
Accum. Depreciation	$787M	$766M	$745M	$724M	$700M	$663M	$630M	$621M	$657M	$635M	·	$580M	$565M	$541M	·	$489M
Goodwill	$4.94B	$4.95B	$4.99B	$4.98B	$5.76B	$5.61B	$5.54B	$5.67B	$5.66B	$5.67B	$5.72B	$5.64B	$5.69B	$5.68B	$5.65B	$5.51B
Intangibles	$2.92B	$3.01B	$3.10B	$3.17B	$3.26B	$3.24B	$3.27B	$3.43B	$3.49B	$3.57B	·	$3.70B	$3.80B	$3.98B	·	$4.01B
Other Non-current Assets	$412M	$442M	$396M	$406M	$391M	$368M	$360M	$420M	$368M	$368M	·	$289M	$277M	$272M	·	$245M
Total Assets	$11.60B	$11.66B	$11.79B	$11.68B	$12.78B	$12.33B	$12.11B	$12.84B	$12.69B	$12.76B	·	$12.80B	$13.06B	$13.40B	·	$13.11B
Accounts Payable	$743M	$736M	$742M	$692M	$709M	$680M	$663M	$674M	$657M	$573M	·	$656M	$687M	$766M	·	$769M
Current Liabilities	$1.38B	$1.37B	$1.38B	$1.52B	$2.58B	$2.03B	$2.01B	$1.63B	$1.46B	$1.44B	·	$1.49B	$1.55B	$1.67B	·	$1.55B
Capital Leases	·	·	$152M	·	·	·	$143M	·	·	·	·	·	·	·	·	·
Deferred Tax	$540M	$550M	$557M	$548M	$536M	$550M	$557M	$547M	$575M	$601M	·	$649M	$663M	$696M	·	$728M
Other Non-current Liabilities	$383M	$377M	$378M	$403M	$391M	$365M	$358M	$419M	$362M	$361M	·	$271M	$269M	$300M	·	$334M
Total Liabilities	$5.97B	$6.07B	$6.23B	$6.11B	$6.49B	$6.23B	$6.16B	$7.29B	$7.26B	$7.43B	·	$7.70B	$8.05B	$8.40B	·	$8.52B
Long-term Debt	$3.70B	$3.82B	$3.95B	$3.86B	$4.24B	$4.11B	$4.06B	$4.92B	$5.12B	$5.32B	·	$5.63B	$5.88B	$6.06B	·	$6.19B
Total Debt	$3.70B	$3.82B	·	$3.86B	$4.24B	$4.11B	·	$4.92B	$5.12B	$5.32B	·	$5.63B	$5.88B	$6.06B	·	$6.19B
Retained Earnings	$1.75B	$1.72B	$1.67B	$1.62B	$2.33B	$2.27B	$2.20B	$1.70B	$1.64B	$1.55B	·	$1.39B	$1.28B	$1.29B	·	$1.03B
Treasury Stock	$76M	$76M	$76M	·	·	·	$0	·	·	·	·	·	·	·	·	·
AOCI	$-55M	$-44M	$-17M	$-24M	$-10M	$-118M	$-184M	$-74M	$-107M	$-97M	·	$-111M	$-72M	$-90M	$-100M	$-212M
Stockholders' Equity	$5.63B	$5.59B	$5.57B	$5.57B	$6.29B	$6.10B	$5.96B	$5.55B	$5.43B	$5.34B	$5.25B	$5.10B	$5.01B	$4.99B	$4.86B	$4.59B
Liabilities + Equity	$11.60B	$11.66B	$11.79B	$11.68B	$12.78B	$12.33B	$12.11B	$12.84B	$12.69B	$12.76B	·	$12.80B	$13.06B	$13.40B	·	$13.11B
Shares Outstanding	·	682,900,000	682,000,000	681,900,000	681,600,000	681,500,000	680,800,000	680,600,000	679,600,000	679,200,000	·	676,300,000	675,700,000	675,100,000	·	674,200,000

현금 흐름 14

지표	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
D&A	$106M	$105M	$103M	$104M	$103M	$100M	$101M	$102M	$103M	$100M	$101M	$98M	$103M	$101M	$101M	$101M
Stock-based Comp	$15M	$9M	$11M	$7M	$16M	$12M	$11M	$12M	$11M	$13M	$9M	$10M	$9M	$13M	$10M	$12M
Deferred Tax	$16M	$-10M	$50M	$-12M	$-18M	$-12M	$28M	$-23M	$-35M	$-18M	$-78M	$-29M	$-38M	$-26M	$-7M	$-22M
Restructuring	·	·	$2M	$2M	·	·	$500.0K	$49M	·	·	$8M	$6M	$7M	$5M	$-200.0K	$1M
Operating Cash Flow	$178M	$59M	$153M	$207M	$154M	$109M	$173M	$245M	$281M	$142M	$252M	$231M	$168M	$220M	$206M	$258M
CapEx	$38M	$34M	$36M	$36M	$30M	$28M	$28M	$41M	$46M	$35M	$51M	$38M	$30M	$28M	$34M	$39M
Investing Cash Flow	$-37M	$-33M	$-40M	$-33M	$-29M	$-29M	$558M	$-40M	$-45M	$-34M	$-50M	$-37M	$-29M	$-27M	$-33M	$4M
Debt Issued	·	·	$1.04B	$68M	$0	$0	$0	$-12M	$-29M	$41M	$0	$0	$0	$0	$82M	$35M
Net Debt Issued	·	$-105M	·	·	·	$-31M	·	·	·	$-169M	·	·	·	$-270M	·	·
Financing Cash Flow	$-112M	$-107M	$700.0K	$-370M	$-7M	$-34M	$-755M	$-199M	$-197M	$-130M	$-184M	$-188M	$-196M	$-275M	$-82M	$-219M
Net Change in Cash	$28M	$-86M	$114M	$-198M	$134M	$54M	$-46M	$14M	$38M	$-28M	$27M	$-100.0K	$-58M	$-78M	$109M	$27M
Taxes Paid	$30M	$10M	$29M	$22M	$77M	$17M	$120M	$42M	$69M	$17M	$29M	$69M	$113M	$14M	$75M	$51M
Free Cash Flow	·	$25M	·	·	·	$81M	·	·	·	$107M	·	·	·	$192M	·	·
Levered FCF	·	$-8M	·	·	·	$50M	·	·	·	$59M	·	·	·	$134M	·	·

수익성 8

지표	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Gross Margin	31.7%	31.7%	·	32.4%	32.9%	33.8%	·	32.9%	34.2%	34.0%	·	33.6%	33.8%	35.1%	·	35.0%
Operating Margin	7.2%	6.3%	·	-40.0%	7.6%	9.3%	·	7.3%	10.3%	8.7%	·	12.2%	4.1%	13.0%	·	14.9%
Net Margin	2.2%	2.7%	·	-43.8%	3.8%	4.1%	·	3.4%	5.5%	3.6%	·	6.3%	-0.42%	6.8%	·	9.0%
Pretax Margin	4.8%	3.5%	·	-42.5%	4.9%	5.4%	·	4.3%	6.7%	4.8%	·	7.9%	-0.07%	8.8%	·	11.2%
EBITDA Margin	7.2%	6.3%	·	-40.0%	7.6%	9.3%	·	7.3%	10.3%	8.7%	·	12.2%	4.1%	13.0%	·	14.9%
ROA	0.31%	0.36%	·	-5.8%	0.51%	0.51%	·	0.45%	0.72%	0.46%	·	0.84%	-0.06%	0.89%	·	1.3%
ROE	0.64%	0.74%	·	-12.8%	1.1%	1.1%	·	1.1%	1.8%	1.2%	·	2.2%	-0.15%	2.6%	·	3.8%
ROIC	0.61%	0.83%	·	-7.1%	0.97%	1.1%	·	0.92%	1.4%	1.0%	·	1.6%	3.7%	1.6%	·	2.1%

유동성 및 지급능력 5

지표	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Current Ratio	1.8	1.8	·	1.5	1.0	1.1	·	1.5	1.6	1.6	·	1.6	1.6	1.6	·	1.6
Quick Ratio	1.0	1.0	·	0.9	0.6	0.7	·	0.8	1.0	0.9	·	0.9	0.9	0.9	·	1.0
Debt / Equity	0.7	0.7	·	0.7	0.7	0.7	·	0.9	0.9	1.0	·	1.1	1.2	1.2	·	1.3
LT Debt / Equity	0.7	0.7	·	0.7	0.5	0.5	·	0.8	0.9	0.9	·	1.0	1.1	1.1	·	1.3
Interest Coverage	3.1	2.3	·	-14.7	3.0	3.5	·	2.6	2.9	2.3	·	2.9	1.0	3.1	·	4.1

효율성 3

지표	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Asset Turnover	0.1	0.1	·	0.1	0.1	0.1	·	0.1	0.1	0.1	·	0.1	0.1	0.1	·	0.1
Inventory Turnover	1.4	1.4	·	1.4	1.4	1.3	·	1.4	1.3	1.3	·	1.3	1.3	1.3	·	1.4
Receivables Turnover	1.5	1.4	·	1.5	1.5	1.4	·	1.5	1.5	1.4	·	1.4	1.4	1.4	·	1.5

주당 5

지표	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Book Value / Share	·	$8.18	·	$8.17	$9.22	$8.95	·	$8.16	$8.00	$7.86	·	$7.54	$7.42	$7.40	·	$6.81
Revenue / Share	$2.50	$2.34	·	$2.38	$2.47	$2.32	·	$2.51	$2.49	$2.47	·	$2.54	$2.58	$2.63	·	$2.73
Cash Flow / Share	·	$0.09	·	·	·	$0.16	·	·	·	$0.21	·	·	·	$0.32	·	·
Cash / Share	·	$0.41	·	$0.37	$0.66	$0.46	·	$0.42	$0.40	$0.35	·	$0.35	$0.35	$0.44	·	$0.39
EPS (TTM)	$-0.84	$-0.81	·	$-0.13	$0.99	$1.04	·	$0.45	$0.53	$0.38	·	$0.53	$0.62	$0.91	·	$0.93

가치 평가 (TTM) 10

지표	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Revenue TTM	$6.56B	$6.55B	·	$6.58B	$6.67B	$6.69B	·	$6.82B	$6.83B	$6.87B	·	$7.04B	$7.18B	$7.34B	·	$7.62B
Net Income TTM	$-578M	$-551M	·	$-82M	$687M	$716M	·	$310M	$360M	$260M	·	$364M	$423M	$618M	·	$639M
Market Cap	·	$5.35B	·	$8.51B	$9.17B	$11.05B	·	$17.61B	$14.41B	$17.37B	·	$14.26B	$13.88B	$14.27B	·	$13.21B
Enterprise Value	·	$8.89B	·	$12.12B	$12.97B	$14.84B	·	$22.24B	$19.25B	$22.46B	·	$19.65B	$19.53B	$20.04B	·	$19.14B
P/E	-11.8	-9.7	·	-96.0	13.6	15.6	·	57.5	40.0	67.3	·	39.8	33.1	23.2	·	21.1
P/S	·	0.8	·	1.3	1.4	1.7	·	2.6	2.1	2.5	·	2.0	1.9	1.9	·	1.7
P/B	·	1.0	·	1.5	1.5	1.8	·	3.2	2.7	3.3	·	2.8	2.8	2.9	·	2.9
P / Cash Flow	·	91.2	·	·	·	101.1	·	·	·	122.6	·	·	·	65.0	·	·
EV / Revenue	·	1.4	·	1.8	1.9	2.2	·	3.3	2.8	3.3	·	2.8	2.7	2.7	·	2.5
Earnings Yield	-8.5%	-10.3%	·	-1.0%	7.4%	6.4%	·	1.7%	2.5%	1.5%	·	2.5%	3.0%	4.3%	·	4.7%

최신 기간은 왼쪽에 · null 값은 ·로 표시

재무제표 손익계산서, 대차대조표, 현금흐름 — 연간, 지난 5년

16

지표	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
매출	$6.55B	$6.78B	$6.97B	$7.51B	$7.39B
매출 총이익률 %	32.6%	33.6%	33.9%	34.6%	33.9%
영업이익률 %	-3.8%	16.0%	10.0%	15.0%	13.2%
순이익	$-530M	$712M	$321M	$686M	$573M
희석 EPS	$-0.78	$1.04	$0.47	$1.01	$0.85

지표	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
부채 / 자기자본 비율	0.7	0.7	1.1	1.3	1.7
유동비율	1.8	1.1	1.6	1.6	1.7
당좌 비율	1.0	0.6	1.0	1.0	1.1

지표	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
잉여현금흐름	$495M	$692M	$724M	$710M	$842M

기관 투자자 (13F) 493개의 제출자 · $7.6B 전체 · 기준일 2026년 9월 30일

17

분기별 SEC 양식 13F에서 이 주식을 보유하고 있다고 보고하는 기관. 롱 포지션만 해당하며, 단일 제출자는 별도의 옵션 레그에 대해 두 번 나타날 수 있습니다. 대규모 상쇄 풋/콜 포지션은 일반적으로 방향성에 대한 확신보다는 시장 조성 또는 헤지된 재고를 반영합니다.

보유자 493

보유 가치 $7.6B

신규 포지션 97

청산 포지션 60

기관 활동 — Q2 2026 대 이전 분기

신규 포지션	청산 포지션	증가함	감소	순주식 변동
97 (-7 이전 분기 대비)	60 (-11 이전 분기 대비)	192 (+31 이전 분기 대비)	113 (-15 이전 분기 대비)	+24.9M

Q1 2026 대비 비교. SEC 양식 13F 제출은 분기 말로부터 45일 이내에 마감되며, 지연 제출자를 위한 짧은 유예 기간이 추가됩니다. 해당 기간 내에 있는 분기는 가장 최근에 완전히 보고된 쌍을 선호하여 건너뜁니다.

기관	가치	주식	% 추적된 13F 중	유형
Dodge & Cox	$1,188,207,643	120,020,974	15.59%	주식
VANGUARD GROUP INC	$743,810,028	64,904,889	9.76%	주식
BlackRock, Inc.	$695,784,194	70,281,231	9.13%	주식
VANGUARD PORTFOLIO MANAGEMENT LLC	$310,298,175	31,343,250	4.07%	주식
VANGUARD CAPITAL MANAGEMENT LLC	$304,948,067	30,802,835	4.00%	주식
GREENHAVEN ASSOCIATES INC	$243,909,369	24,637,310	3.20%	주식
STATE STREET CORP	$213,572,443	21,572,974	2.80%	주식
DIMENSIONAL FUND ADVISORS LP	$202,086,268	20,412,181	2.65%	주식
Engine Capital Management, LP	$196,622,217	19,860,830	2.58%	주식
BARROW HANLEY MEWHINNEY & STRAUSS LLC	$195,386,083	19,735,968	2.56%	주식
New Mountain Capital, L.L.C.	$138,600,000	14,000,000	1.82%	주식
Invesco Ltd.	$137,465,065	13,885,360	1.80%	주식
GEODE CAPITAL MANAGEMENT, LLC	$130,519,321	13,180,567	1.71%	주식
MARSHALL WACE, LLP	$129,988,565	13,130,158	1.71%	주식
AQR CAPITAL MANAGEMENT LLC	$115,112,902	11,627,566	1.51%	주식
BANK OF AMERICA CORP /DE/	$108,794,506	10,989,344	1.43%	주식
EARNEST PARTNERS LLC	$106,410,397	10,748,525	1.40%	주식
LONDON CO OF VIRGINIA	$103,811,008	10,485,960	1.36%	주식
FULLER & THALER ASSET MANAGEMENT, INC.	$101,537,816	10,256,345	1.33%	주식
D. E. Shaw & Co., Inc.	$94,758,077	9,571,523	1.24%	주식
First Pacific Advisors, LP	$81,088,326	8,190,740	1.06%	주식
SEI INVESTMENTS CO	$78,677,367	7,947,198	1.03%	주식
FMR LLC	$77,670,074	7,845,462	1.02%	주식
GENDELL JEFFREY L	$75,311,973	7,607,270	0.99%	주식
VAUGHAN NELSON INVESTMENT MANAGEMENT, L.P.	$73,188,967	7,392,825	0.96%	주식
Clarkston Capital Partners, LLC	$67,214,209	6,789,314	0.88%	주식
MORGAN STANLEY	$66,905,804	6,758,161	0.88%	주식
GOLDMAN SACHS GROUP INC	$61,422,976	6,204,341	0.81%	주식
NORGES BANK	$60,307,949	6,091,712	0.79%	주식
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	$57,627,950	5,821,005	0.76%	주식
NORTHERN TRUST CORP	$56,753,512	5,732,678	0.74%	주식
Freestone Grove Partners LP	$56,577,352	5,714,884	0.74%	주식
UBS Group AG	$56,155,742	5,672,297	0.74%	주식
AMERIPRISE FINANCIAL INC	$54,696,928	5,524,942	0.72%	주식
YACKTMAN ASSET MANAGEMENT LP	$47,223,000	4,770,000	0.62%	주식
SOUTHEASTERN ASSET MANAGEMENT INC/TN/	$46,782,232	4,725,478	0.61%	주식
Brickwood Asset Management LLP	$45,515,438	4,597,519	0.60%	주식
VANGUARD FIDUCIARY TRUST CO	$42,790,226	4,322,245	0.56%	주식
JONES FINANCIAL COMPANIES LLLP	$42,363,659	4,120,981	0.56%	주식
Bank of New York Mellon Corp	$40,800,098	4,121,222	0.54%	주식
ROYCE & ASSOCIATES LP	$36,393,232	3,676,084	0.48%	주식
FRONTIER CAPITAL MANAGEMENT CO LLC	$34,719,001	3,506,970	0.46%	주식
PRIVATE MANAGEMENT GROUP INC	$30,662,617	3,097,234	0.40%	주식
Voss Capital, LP	$26,235,000	2,650,000	0.34%	주식
Prescott General Partners LLC	$25,740,000	2,600,000	0.34%	주식
Gotham Asset Management, LLC	$24,912,796	2,516,444	0.33%	주식
Quantinno Capital Management LP	$24,177,175	2,442,138	0.32%	주식
KINNEY ASSET MANAGEMENT, LLC	$23,025,600	1,845,000	0.30%	주식
Loews Corp	$21,780,000	2,200,000	0.29%	주식
Western Standard LLC	$20,888,842	2,109,984	0.27%	주식

전체 493 기관 투자자 보기 →

행동주의자 및 5% 이상 소유자 1 보유

18

SEC 서류 13D를 제출한 투자자 — 발행인에 영향을 미치려는 의도로 5% 이상의 실질 소유권(행동주의 지분, 이사회 캠페인, M&A). 각 행은 해당 제출자의 포지션에 대한 가장 최근에 알려진 상태를 보여줍니다.

제출자	제출됨	지분	상태	목적	제출
The Goldman Sachs Group, Inc., Goldman Sachs & Co. LLC, Broad Street Principal Investments, L.L.C., Bridge Street Opportunity Advisors, L.L.C., StoneBridge 2017, L.P., StoneBridge 2017 Offshore, L.P., StoneBridge 2018, L.P., StoneBridge 2018 Offshore, L.P., VWR Partners, L.P. ×8 제출 서류	2021년 5월 7일	·	최초 제출	·	SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

회사 내부자 47 명의 내부자 · 29 임원 · 20 이사

19

내부자	역할	마지막 활동	보유 주식 수	매수 12개월	순매수/매도 12개월
Emmanuel Ligner	President and CEO	2026년 8월 18일 F	737,334	1	$993,125
Michael Stubblefield	President & CEO	2025년 5월 21일 G	545,500	0	$0
Todd W. Garner	EVP and CFO	2026년 9월 21일 A	49,688	0	$0
Brent R. Jones	EVP, Chief Financial Officer	2026년 2월 23일 F	419,782	0	$0
Thomas A Szlosek	EVP & CFO	2023년 5월 17일 F	77,489	0	$0
Corey Walker	President, VWR Dist. & Servs.	2026년 6월 21일 F	384,535	0	$0
Mary Blenn	EVP, Chief Operating Officer	2026년 2월 19일 A	253,384	0	$0
Bjorn Hofman	EVP and COO	2019년 5월 21일 A	157,143	0	$0
Brittany Hankamer	EVP, Chief HR Officer	2026년 8월 14일 F	248,864	0	$0
Steven W Eck	SVP & Chief Accounting Officer	2026년 7월 31일 F	129,593	0	$0
Claudius Sokenu	EVP, Chief Legal & Compliance	2026년 7월 24일 F	251,228	0	$0
Ludovic Brellier	EVP, Bioscience & Medtech	2026년 5월 1일 A	146,566	0	$0
Benoit Gourdier	EVP, Bioscience & Medtech	2026년 2월 23일 F	362,859	0	$0
Christophe Couturier	EVP, AMEA	2025년 8월 8일 A	211,271	0	$0
James Bramwell	EVP Sales, Customer Excellence	2025년 2월 27일 S	86,605	0	$0
Kitty Sahin	EVP, Strategy&Corp Development	2024년 7월 18일 F	42,274	0	$0
Randy Lee Stone	EVP, Laboratory Solutions	2024년 4월 16일 F	68,105	0	$0
Sheri Lewis	EVP, Global Ops & Supply Chain	2023년 12월 31일 F	70,692	0	$0
Frederic Vanderhaegen	EVP, Americas and Europe	2023년 8월 25일 S	160,735	0	$0
Justin Miller	EVP & General Counsel	2023년 5월 17일 F	93,336	0	$0
Gerard Brophy	EVP, Biopharma Production	2023년 5월 17일 F	89,032	0	$0
Meghan Henson	EVP, Chief HR Officer	2023년 2월 24일 A	40,184	0	$0
Michael Wondrasch	EVP & CIO	2023년 2월 20일 F	96,072	0	$0
Mark Christopher Murray	EVP, Biomaterials & AT	2022년 1월 13일 F	18,680	0	$0
Devashish Ohri	EVP, IMEA	2021년 5월 27일 M	139,095	0	$0
Sven Henrichwark	EVP, APAC Region	2021년 2월 25일 A	19,802	0	$0
Eric Mcallister	EVP, CHRO	2020년 5월 17일 F	197,899	0	$0
Tanya Foxe	EVP, Operations & Supply Chain	2020년 2월 21일 A	39,458	0	$0
Ashish Kulkarni	EVP and Chief Technology Officer	2019년 5월 21일 A	128,571	0	$0
Gregory T Lucier	이사	2026년 5월 8일 P	60,000	2	$541,200
Simon Dingemans	이사	2026년 5월 7일 A	31,495	1	$203,500
Louise Makin	이사	2026년 5월 7일 A	47,140	0	$0
Mala Murthy	이사	2026년 5월 7일 A	69,479	0	$0
Michael Severino	이사	2026년 5월 7일 A	85,821	0	$0
Joseph R Massaro	이사	2026년 5월 7일 A	77,408	0	$0
Gregory L Summe	이사	2026년 5월 7일 A	83,381	2	$2,065,000
Sanjeev K Mehra	이사	2026년 5월 7일 A	33,376	2	$4,882,750
John Carethers	이사	2025년 5월 8일 A	45,858	0	$0
Lan Kang	이사	2025년 5월 8일 A	52,315	0	$0
Juan Andres	이사	2025년 5월 8일 A	65,480	0	$0
Jonathan M Peacock	이사	2025년 5월 8일 A	219,815	0	$0
Christi Shaw	이사	2023년 5월 11일 A	36,271	0	$0
Matthew S. Holt	이사	2022년 5월 12일 A	7,908	0	$0
Rajiv Gupta	이사	2022년 4월 1일 A	780,562	0	$0
Jo Natauri	이사	2021년 7월 12일 P	557,656	0	$0
Rakesh Sachdev	이사	2021년 2월 25일 A	32,841	0	$0
Thomas Connolly	이사	2020년 6월 18일 S	72,620,082	0	$0

SEC 양식 3/4/5 제출 서류 기준 내부자; 순매수/매도는 공개 시장 거래만 해당

ETF 보유 현황 56 ETF 보유

20

가중치는 직접적인 주식 보유(N-PORT)만 반영합니다. 레버리지 또는 파생 상품 기반 펀드는 표시되지 않은 추가 스왑 노출을 보유할 수 있습니다.

펀드	비중	단위	기준일	출처
LSEQ · Harbor ETF Trust	2.52%	27,960 NS	2026년 7월 31일	N-PORT
EPSB · Harbor ETF Trust	1.77%	6,133 NS	2026년 7월 31일	N-PORT
BSJS · Invesco Exchange-Traded Self-Indexe…	1.51%	11,851,000	2026년 10월 2일	일간
DFSV · Dimensional ETF Trust	0.52%	3,118,943 NS	2026년 7월 31일	N-PORT
BKSE · BNY Mellon ETF Trust	0.40%	25,471 NS	2026년 7월 31일	N-PORT
IVOV · VANGUARD ADMIRAL FUNDS	0.39%	586,296 SH	2026년 8월 19일	일간
QVMM · Invesco Exchange-Traded Fund Trust …	0.32%	88,836 SH	2026년 10월 2일	일간
RWK · Invesco Exchange-Traded Fund Trust …	0.27%	230,747 SH	2026년 10월 2일	일간
VFVA · VANGUARD WELLINGTON FUND	0.27%	233,604 SH	2026년 8월 19일	일간
PTMC · Pacer Funds Trust	0.27%	75,616 NS	2026년 7월 31일	N-PORT
NUSC · Nushares ETF Trust	0.20%	188,520 NS	2026년 7월 31일	N-PORT
MIDU · Direxion Shares ETF Trust	0.20%	10,027 NS	2026년 7월 31일	N-PORT
ESML · iShares Trust	0.20%	376,218 SH	2026년 9월 11일	일간
BBMC · J.P. Morgan Exchange-Traded Fund Tr…	0.19%	286,321 NS	2026년 7월 31일	N-PORT
IVOO · VANGUARD ADMIRAL FUNDS	0.19%	1,104,592 SH	2026년 8월 19일	일간
DFAT · Dimensional ETF Trust	0.17%	1,765,932 NS	2026년 7월 31일	N-PORT
DFAS · Dimensional ETF Trust	0.17%	1,854,609 NS	2026년 7월 31일	N-PORT
IYH · iShares Trust	0.16%	386,410 SH	2026년 9월 11일	일간
VBR · VANGUARD INDEX FUNDS	0.14%	9,920,672 SH	2026년 8월 19일	일간
SMMD · iShares Trust	0.14%	351,599 SH	2026년 9월 11일	일간
FHLC · FIDELITY COVINGTON TRUST	0.13%	313,238 NS	2026년 7월 31일	N-PORT
REVS · Columbia ETF Trust I	0.12%	28,653 NS	2026년 7월 31일	N-PORT
VHT · VANGUARD WORLD FUND	0.10%	1,983,361 SH	2026년 8월 19일	일간
IWS · iShares Trust	0.10%	978,878 SH	2026년 9월 11일	일간
EQAL · Invesco Exchange-Traded Fund Trust …	0.10%	50,803 SH	2026년 10월 2일	일간
WSML · iShares Trust	0.09%	41,659 SH	2026년 9월 11일	일간
VXF · VANGUARD INDEX FUNDS	0.08%	7,835,858 SH	2026년 8월 19일	일간
VB · VANGUARD INDEX FUNDS	0.08%	15,636,784 SH	2026년 8월 19일	일간
TILT · FlexShares Trust	0.08%	121,976 NS	2026년 7월 31일	N-PORT
RECS · Columbia ETF Trust I	0.08%	325,274 NS	2026년 7월 31일	N-PORT
IWR · iShares Trust	0.07%	2,700,866 SH	2026년 9월 11일	일간
IUS · Invesco Exchange-Traded Self-Indexe…	0.06%	37,709 SH	2026년 10월 2일	일간
PRF · Invesco Exchange-Traded Fund Trust	0.04%	251,941 SH	2026년 10월 2일	일간
IUSV · iShares Trust	0.03%	593,664 SH	2026년 9월 11일	일간
DXUV · Dimensional ETF Trust	0.03%	11,452 NS	2026년 7월 31일	N-PORT
IWD · iShares Trust	0.03%	1,462,438 SH	2026년 9월 11일	일간
VONV · VANGUARD SCOTTSDALE FUNDS	0.02%	397,791 SH	2026년 8월 19일	일간
IYY · iShares Trust	0.01%	29,349 SH	2026년 9월 11일	일간
IWB · iShares Trust	0.01%	457,613 SH	2026년 9월 11일	일간
ITOT · iShares Trust	0.01%	885,606 SH	2026년 9월 11일	일간
IWV · iShares Trust	0.01%	183,968 SH	2026년 9월 11일	일간
VTI · VANGUARD INDEX FUNDS	0.01%	21,681,946 SH	2026년 8월 19일	일간
VT · VANGUARD INTERNATIONAL EQUITY INDEX…	0.01%	534,809 SH	2026년 8월 19일	일간
VONE · VANGUARD SCOTTSDALE FUNDS	0.01%	109,164 SH	2026년 8월 19일	일간
VTHR · VANGUARD SCOTTSDALE FUNDS	0.01%	55,632 SH	2026년 8월 19일	일간
ESGV · VANGUARD WORLD FUND	0.01%	149,286 SH	2026년 8월 19일	일간
NEAR · iShares U.S. ETF Trust	0.01%	365,000 SH	2026년 9월 9일	일간
DFUS · Dimensional ETF Trust	0.00%	5,257 NS	2026년 7월 31일	N-PORT
DFSU · Dimensional ETF Trust	0.00%	544 NS	2026년 7월 31일	N-PORT
DFAU · Dimensional ETF Trust	0.00%	1,476 NS	2026년 7월 31일	N-PORT
DFAC · Dimensional ETF Trust	0.00%	2,958 NS	2026년 7월 31일	N-PORT
IJH · iShares Trust	·	23,957,709 SH	2026년 9월 11일	일간
IJJ · iShares Trust	·	3,487,441 SH	2026년 8월 31일	일간
XJH · iShares Trust	·	93,400 SH	2026년 9월 8일	일간
ISCB · iShares Trust	·	29,420 SH	2026년 9월 11일	일간
ISCV · iShares Trust	·	144,718 SH	2026년 9월 11일	일간

AVTR 분석가 합의 강세 및 약세 애널리스트 의견, 12개월 목표 주가, 상승 여력

21

평점 · 25 명의 애널리스트 보유

중앙값 목표 $14.40 -6.1%

3 12.0% 적극 매수

5 20.0% 매수

16 64.0% 보유

1 4.0% 매도

0 0.0% 적극 매도

12개월 목표 주가

15 명의 애널리스트 · 2026-09-28

평균 목표 $14.66 -4.4%

지금 현재가 $15.34

저가$12.00 평균$14.66 고가$19.00

동종 기업 비교(GICS 하위 산업) 주요 지표 대 섹터 동종 기업

22

회계연도 기준, 각 회사의 마지막 회계연도 말 종가 기준 가격입니다.

티커	시가총액	P/E	매출 YoY	순이익률	ROE	매출 총이익률
AVTR	$7.82B	-14.7	-3.4%	-8.1%	-8.9%	32.6%
TEM	·	-41.9	83.4%	-19.3%	-61.2%	·
TEM	·	-41.9	83.4%	-19.3%	-61.2%	·
CRL	$10.02B	-70.0	-0.85%	-3.6%	-4.4%	·
TXG	$2.08B	-46.6	5.2%	-6.8%	-5.5%	69.0%
TECH	$11.03B	60.9	-0.38%	15.0%	9.0%	65.8%
RGEN	$9.23B	190.5	16.4%	6.6%	2.4%	·
BRKR	$7.17B	-314.1	2.1%	-0.25%	-0.40%	45.9%
BIO	·	·	·	·	·	·
SHC	$5.02B	65.3	5.7%	6.7%	14.0%	55.5%
ADPT	$2.50B	-41.6	54.8%	-21.5%	-28.2%	·

나의 지표 나만의 관심 목록 — 전체 기본 재무제표에서 선택한 항목

26

중요한 지표를 선택하세요. 상단의 전체 기본 정보에서 원하는 행 옆의 +를 클릭하세요.

선택 항목이 저장되어 모든 티커에서 유지됩니다.

AVTR Avantor, Inc. Common Stock